Jun Li

Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models

M. Schulte, Allie Fu, Ping Zhao et al. · Nature Medicine · 2018 · 486 citations

Medicine, Oncology, Pharmacology +6

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo et al. · Cell · 2018 · 438 citations · Full text

Medicine, Cancer Biology, Oncology +17

TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9

Leonhard X. Heinz, JangEun Lee, Utkarsh Kapoor et al. · Nature · 2020 · 225 citations · Full text

Life Sciences, Immunology, Molecular Biology +8

Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009

Keisha A. Houston, S. Jane Henley, Jun Li et al. · Lung Cancer · 2014 · 222 citations · Full text

Medicine, Oncology, Pathology +17

HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma

Jun Li, Xiaochen Wang, Junwei Tang et al. · Cellular Physiology and Biochemistry · 2015 · 211 citations · Full text

Medicine, Molecular Medicine, Oncology +17